亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Balloon guide catheter versus different sizes of non-balloon guide catheter; a MR CLEAN Registry analysis

医学 气球 改良兰金量表 导管 随机对照试验 外科 内科学 缺血性中风 缺血
作者
Robrecht R.M.M. Knapen,Robert‐Jan B. Goldhoorn,Jeannette Hofmeijer,Geert J. Lycklamaà Nijeholt,René van den Berg,Ido R. van den Wijngaard,Robert J. van Oostenbrugge,Wim H. van Zwam,Christiaan van der Leij
出处
期刊: [Cold Spring Harbor Laboratory]
被引量:1
标识
DOI:10.1101/2023.07.07.23292400
摘要

Abstract Introduction Balloon guide catheters (BGC) are used to prevent distal emboli during endovascular treatment (EVT) for acute ischemic stroke. Although literature reports benefit of BGC, these are not universally used and randomized head-to-head comparisons are lacking. This study compared functional, safety, and technical outcomes between patients treated with different sizes non-BGC and with BGC during EVT in a nationwide prospective multicenter registry. Methods Patients from the MR CLEAN Registry (2014–2018), who underwent EVT with a 5-7French (Fr) non-BGC, a 8-9Fr non-BGC, or a 8-9Fr BGC were included. Primary outcome was the modified Rankin Scale (mRS) score at 90 days, secondary outcomes included procedure time and first-attempt successful reperfusion (eTICI ≥ 2C). Treatment-effect modification and subgroups were analyzed according to first-line thrombectomy technique: stent retriever (SR) or direct aspiration (ASP). Results In total 2808 patients were included, and 1671 (60%) were treated with 8-9Fr BGC. Overall, no significant differences in clinical outcome were seen between non-BGC and BGC groups. The 8-9Fr non-BGC was associated with lower first-attempt successful revascularization rates compared to BGC (aOR:0.76, 95%CI:0.59-0.998), the 5-7 Fr non-BCG was not. Regression analysis showed a significant interaction between BGC use and device type. In the subgroup with SR as first-line technique, 90 day mRS scores were significantly higher in the 8-9Fr non-BGC group compared with BCG (acOR:0.77; 95%CI:0.59-0.996), but not in the 5-7Fr non-BCG. Direct aspiration combined with 5-7Fr non-BGC resulted in higher first-attempt rates compared to BGC (aOR:1.75; 95%CI:1.16-2.63). Conclusion This large prospective multicenter registry showed no differences in clinical outcome between patients treated with 5-7Fr non-BGC, 8-9Fr non-BGC, and 8-9Fr BGC. Subgroup analyses, however, suggest that BCG outperforms the non-BGC when SR is used as first-line technique.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
一去发布了新的文献求助10
2秒前
谎1028完成签到 ,获得积分10
7秒前
梦想家发布了新的文献求助10
7秒前
神勇凡英完成签到,获得积分10
10秒前
苗条雅彤完成签到,获得积分10
11秒前
Ayanami完成签到 ,获得积分10
15秒前
15秒前
21秒前
漂亮凌旋发布了新的文献求助10
22秒前
大气的湘完成签到,获得积分10
24秒前
兮颜完成签到 ,获得积分10
28秒前
kyhoy完成签到 ,获得积分10
30秒前
35秒前
梦想家发布了新的文献求助10
37秒前
英俊的铭的应助被斯文的初柔采纳,获得10
42秒前
科研狗完成签到 ,获得积分10
42秒前
44秒前
Jmuran完成签到 ,获得积分10
44秒前
45秒前
47秒前
剑烟发布了新的文献求助10
49秒前
allezallez完成签到,获得积分10
50秒前
懵懂的小之完成签到,获得积分10
50秒前
51秒前
机智的如曼完成签到,获得积分10
53秒前
1分钟前
传奇3的应助被ghx采纳,获得10
1分钟前
1分钟前
inRe完成签到,获得积分10
1分钟前
1分钟前
清爽的孤丝完成签到,获得积分10
1分钟前
1分钟前
如意紫翠完成签到,获得积分10
1分钟前
1分钟前
yihuifa完成签到 ,获得积分10
1分钟前
刘厚麟的应助被科研通管家采纳,获得10
1分钟前
传奇3的应助被科研通管家采纳,获得10
1分钟前
1分钟前
顺利秋天完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)通过应助OA文献获取积分 10000
Rosenblum, Global Change Biology 800
Computational Chemical Reaction Engineering: Modeling, Simulation, and Design with MATLAB 600
Organizational Behavior 510
Management and the Arts 510
A Will for the Machine: Computerization, Automation, and the Arts in South Africa 400
Decentring Leadership 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 内科学 物理 有机化学 化学工程 生物化学 复合材料 光电子学 细胞生物学 心理学 量子力学 催化作用 物理化学 电极
热门帖子
关注 科研通微信公众号,转发送积分 7809514
求助须知:如何正确求助?哪些是违规求助? 9341728
关于积分的说明 20508318
捐赠科研通 7402149
什么是DOI,文献DOI怎么找? 3329159
关于科研通互助平台的介绍 2475900
邀请新用户注册赠送积分活动 2347830